PRKG2 and neoplasm: The aMD4-bearing OKT3 addbody clearly induced heterotypic cell–cell attachment while the parent OKT3 antibody induced no attachment above background (Fig. 5d), indicating that this addbody could efficiently bridge two specific cell types in a manner similar to the bispecific antibodies used in the therapies for redirecting immune effector cells to tumor cells18.